D-1279-2014 Class II Terminated
FDA drug recall D-1279-2014 was initiated by Legacy Pharmaceutical Packaging on Feb 14, 2014 and is designated Class II. Reason for recall: Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor. The recall status is terminated (terminated Nov 27, 2017). Affected quantity: 667,068 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- May 7, 2014
- Initiation Date
- Feb 14, 2014
- Termination Date
- Nov 27, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 667,068 bottles
Product Description
Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR 72716; Manufactured by: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC 68645-130-54, UPC 3 68645 13054 5.
Reason for Recall
Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.
Distribution Pattern
Nationwide
Code Information
Lot numbers: 131328, Exp 08/15; 131634, Exp 09/15; and 131833, Exp 11/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1279-2014
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026